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BASIC RESEARCH ARTICLE
Quality of life and post-traumatic stress disorder among adult females with 
cancer in Palestine: a cross-sectional study
Beesan Nader Maraqa and Muna Ahmead
Faculty of Public Health, Al-Quds University, Jerusalem, Palestine
ABSTRACT
Background: Little research has been conducted on the quality of life (QoL), functional status, 
and traumatic symptoms related to the diagnosis and treatment of cancer in the Arab region, 
particularly in Palestine, where the psychological problems in patients with cancer are often 
neglected.
Objective: The aim of the study was to assess QoL and post-traumatic stress disorder (PTSD) 
symptoms among adult female patients with cancer attending Beit-Jala Governmental Hospital 
in Bethlehem.
Method: Participants were recruited from 4 April 2015 to the end of July 2015. The sample 
included 253 female patients with cancer attending Beit-Jala Governmental Hospital in 
Bethlehem. Data were collected using self-reported questionnaires, including a socio-demo-
graphic data sheet, the European Organisation for Research and Treatment of Cancer Quality of 
Life Questionnaire Core 30, and the post-traumatic stress disorder checklist for PTSD 
symptoms.
Results: The current study showed poor global QoL (57.4%) and poor physical function (48.5%) 
for female patients with cancer. Insomnia, fatigue, and loss of appetite were the most trouble-
some symptoms that the participants complained about. The prevalence of PTSD symptoms 
was 3%. Regarding PTSD symptom severity, 2% reported severe symptoms, 23.3% reported 
moderate symptoms, and (68.8%) reported mild symptoms, based on a 1991 classification of 
PTSD symptom severity scores. Finally, Pearson’s test revealed a strong, statistically significant, 
inverse relationship between QoL domains and PTSD.
Conclusion: The study found that the overall QoL of female patients with cancer was low and 
strongly associated with PTSD symptoms, suggesting that early detection and treatment of 
these symptoms is critical.
Calidad de vida y trastorno de estrés postraumático en mujeres adultas 
con cáncer en Palestina. Un estudio transversal
Antecedentes: Se han realizado pocas investigaciones sobre la calidad de vida (CdV), el estado 
funcional, y los síntomas traumáticos relacionados con el diagnóstico y el tratamiento del 
cáncer en la región árabe, en particular en Palestina, donde los problemas psicológicos de los 
pacientes con cáncer a menudo se descuidan.
Objetivos: El objetivo del estudio fue evaluar los síntomas de CdV y trastorno de estrés 
postraumático (TEPT) entre las pacientes adultas con cáncer que asisten al Hospital 
Gubernamental de Beit-Jala en Belén.
Método: Los participantes fueron reclutados desde el 4 de abril de 2015 hasta finales de julio 
de 2015. La muestra incluyó 253 pacientes con cáncer que asistían al Hospital Gubernamental 
de Beit-Jala en Belén. Los datos se recopilaron usando cuestionarios autoinformados, 
incluyendo la hoja de datos sociodemográficos, el Cuestionario de Calidad de Vida Core 30 
(QLQC30 en su sigla en inglés) de la Organización Europea para la Investigación y el 
Tratamiento del Cáncer (EORTC en su sigla en inglés) y la lista de verificación del trastorno 
de estrés postraumático (PCL-S en su sigla en inglés) para los síntomas de TEPT.
Resultados: El estudio actual mostró una mala calidad de vida global (57,4%) y una función 
física deficiente (48,5%) para las pacientes con cáncer. El insomnio, la fatiga, y la pérdida de 
apetito fueron los síntomas más molestos de los que se quejaron las participantes. La pre-
valencia de los síntomas de TEPT fue del 3%. Para la gravedad de los síntomas de TEPT, (2%) 
informó síntomas graves, (23,3%) informó síntomas moderados y (68,8%) informó síntomas 
leves según la clasificación de las puntuaciones de la gravedad de los síntomas del TEPT de 
Weathers et al. (1991). Finalmente, la prueba de Pearson reveló una fuerte relación inversa y 
estadísticamente significativa entre los dominios de la calidad de vida y TEPT.
Conclusión: El estudio encontró que la calidad de vida general de las pacientes con cáncer era 
baja y está fuertemente asociada con síntomas de TEPT, lo que sugiere que la detección 
temprana y el tratamiento de estos síntomas es fundamental.
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• Post-traumatic stress disor-
der is being increasingly 
diagnosed among patients 
with cancer, in addition to 
low quality of life. 
• The literature reveals a lack 
of studies in Palestine 
assessing these problems 
in female patients with 
cancer. 
• A cross-sectional study 
including 253 patients with 
cancer using three self- 
reported questionnaires 
was conducted. 
• Job loss circumstances and 
coping strategies (but not 
socio-demographic and 
work variables) were asso-
ciated with class 
membership.  
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巴勒斯坦成年女性癌症患者的生活质量和创伤后应激障碍:横断面研究
背景: 关于阿拉伯地区, 有关癌症诊断和治疗的生活质量 (QoL), 功能状态和创伤症状的研究 
很少, 特别是在巴勒斯坦, 癌症患者的心理问题常被忽略° 目的: 本研究旨在评估在伯利恒贝特贾拉政府医院就诊的成年女性癌症患者的 QOL 和 PTSD 
症状° 方法: 从 2015 年 4 月 4 日至 2015 年 7 月底招募参与者° 样本包括 253 名在伯利恒贝特贾拉 
政府医院就诊的女性癌症患者° 数据由自我报告问卷收集, 包括社会人口学数据表, 欧洲癌症 
研究和治疗组织 (EORTC), 生活质量核心问卷 (QLQC30) 和创伤后应激障碍后检查表 (PCL-S) 
症状° 结果: 目前研究表明, 女性癌症患者的整体生活质量较差 (57.4％), 身体功能较差 (48.5％) ° 失 
眠, 疲劳和食欲不振是参与者抱怨最麻烦的症状°  PTSD 症状的患病率为3％° 对于PTSD 症状 
严重程度, 基于 Weathers (1991) 等, (2％) 报告为严重症状, (23.3％) 报告为中度症状, (68.8％) 
报告为轻度症状°  PTSD 症状严重程度评分的分类° 最终, 皮尔逊 (Pearson) 检验揭示了生活质 
量与 PTSD 之间存在统计学上强显著的反比关系° 结论: 研究发现, 女性癌症患者的整体生活质量较低, 并且与 PTSD 症状密切相关, 这表明早期 
检测和治疗这些症状至关重要° 
1. Introduction
Cancer is among the leading causes of morbidity and 
mortality worldwide, particularly in women. Of the 
18.1 million new cases and 9.1 million cancer-related 
deaths in 2018, half occurred in females (IARC, 2018). 
Breast cancer is the most common female cancer 
worldwide, contributing to more than 25% of the 
total number of new cases diagnosed in 2018. 
Moreover, in Arab countries, 50% of cases are younger 
than 50 years compared to 25% in developed coun-
tries. Breast cancer is still associated with stigma and is 
taboo in most Arab countries (El Saghir et al., 2007), 
which strongly affects the psychological well-being of 
Arab women (El Saghir et al., 2007). Breast cancer is 
also the leading cause of cancer death in women 
(World Health Organization [WHO], 2018; 
Palestinian Ministry of Health, 2018). In Palestine, 
while cancer in general is the second most common 
cause of death, breast cancer is the most commonly 
diagnosed cancer in women (14.2% of all cancer cases, 
with an incidence rate of 13.2% per 100,000 popula-
tion) (Jubran, Shaar, Hammad, & Jarra, 2019). In 
2016, 60% of Palestinian women with breast cancer 
had died prematurely (WHO, 1997).
Quality of life (QoL) and its associated issues 
have become a vital area of concern to cancer 
survivors, their families, and care providers. QoL 
is defined as individuals’ perceptions of their posi-
tion in life in the context of the culture and value 
systems in which they live and in relation to their 
goals, expectations, standards, and concerns. It is a 
broad-ranging concept affected in a complex way 
by the person’s physical health, psychological state, 
level of independence, social relationships, and 
relationships to salient features of their environ-
ment (Quinn, Gonçalves, Sehovic, Bowman, & 
Reed, 2015).
Cancer survivors are more likely to have ‘worse’ or 
impaired QoL compared with the general population, 
regardless of other demographic factors (Quinn et al., 
2015). A 2008 study showed that patients with breast 
cancer had low global QoL scores at 18 months post- 
cancer diagnosis (Montazeri et al., 2008).
Every patient with cancer experiences a range 
of practical, psychological, and emotional chal-
lenges as a result of their diagnosis and treat-
ment-related adverse effects (Adler, 2008). 
Anxiety and distress may affect a patient’s ability 
to cope with the cancer diagnosis or the treatment 
(NCI, 2015a). Post-traumatic stress disorder 
(PTSD) is included in Trauma and Stressor- 
Related Disorders category of the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth 
Edition (DSM-5), with symptoms that occur fol-
lowing exposure to an extreme traumatic stress 
involving the direct personal experience of an 
event that involves actual or threatened death, 
serious injury, unexpected or violent death, ser-
ious harm, or threat of death or injury experi-
enced by a family member or other close associate.
These symptoms include recurrent, involuntary, and 
intrusive distressing memories, dreams about and flash-
backs to the traumatic event(s); intense or prolonged 
psychological distress with exposure to internal or 
external cues that symbolize or resemble an aspect of 
the traumatic event(s); persistent avoidance of stimuli 
associated with the trauma and numbing of general 
responsiveness; negative alterations in cognitions and 
mood associated with the traumatic event(s), such as 
markedly diminished interest or participation in signif-
icant activities, feelings of detachment or estrangement 
from others; and persistent symptoms of increased 
arousal (American Psychiatric Association [APA], 
2013).
Since cancer is an experience of repeated trauma, 
patients with cancer may experience stress symptoms 
at any stage from diagnosis to completion of treatment 
or cancer recurrence (NCI, 2015b). PTSD has been 
increasingly diagnosed as a comorbidity among patients 
with cancer (Mulligan Elizabeth, Wachen, Naik, & 
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Jeffrey Gosian, 2014). About 9.6% of the breast cancer 
patients develop PTSD symptoms, according to a recent 
meta-analysis (Wu, Wang, Cofie, Kaminga, & Liu, 
2016). On the other hand, recent literature critiques 
PTSD diagnosis among patients with cancer, and 
recommends that other diagnoses should be considered 
(Cordova, Riba, & Spiegel, 2017). A 2019 qualitative 
research study in which 2141 patients were interviewed 
supports these critiques (Esser et al., 2019).
Cordova et al. (1995) was the first study to assess 
QoL and define PTSD-like symptoms in 55 women 
after breast cancer treatment. PTSD symptoms were 
negatively related to QoL, and PTSD prevalence was 
5–10%. A large study of long-term breast cancer sur-
vivors (IARC, 2018, p. 083) reports psychosocial co- 
morbidities such as PTSD (12%), and the association 
with QoL suggests the need for screening and psycho-
social support services (Mehnert & Koch, 2008).
The literature review shows only one study in the 
Arab world, which reveals a high prevalence in PTSD 
assessment in breast cancer patients (Aqeel, Mushtaq, 
& Eman, 2019). There are no studies in the Arabic 
world, or in Palestine, that have assessed QoL and its 
relationship to PTSD symptoms among female cancer 
patients.
On the other hand, many of the studies that were 
conducted to assess the QoL among Arabic patients 
with cancer have found it to be low, and emphasized 
the importance of the psychological factors in treating 
these patients. For example, in Egypt, about 40% of 
women with breast cancer at an oncology centre had 
poor QoL (Haddou Rahou et al., 2016).
In addition, one study assessed the determinants of 
the QoL in Palestinian patients with cancer in general, 
and the findings showed poor health-related QoL. It 
also showed a low mean score for global quality of life 
(GQoL) (41.8) and other functional domains, such as 
physical, role, and emotional scales, which were below 
half of full functioning (48.5, 48.8, and 46, respec-
tively). The study authors recommended that the psy-
chological services be integrated into the Palestinian 
healthcare system for patients with cancer to improve 
their QoL and reduce their suffering (European 
Organisation for Research and Treatment of Cancer 
[EORTC], 2001).
Alawadi and Ohaeri (2009) found a low QoL of 348 
patients with breast cancer aged between 20 and 
81 years. The study concluded that psychosocial prog-
nosis in Arab patients with cancer is an important 
aspect of their treatment plan, and recommended the 
institution of a psycho-oncology service to address the 
psychosocial issues (Weathers et al., 2013).
In summary, the serious psychological (e.g. PTSD) 
and social burdens of cancer diagnosis on Palestinian 
women go further than the physical effects, and greatly 
influence their QoL (Palestinian Ministry of Health, 
2018) because of the fragmentation of the health 
system, a high rate of premature deaths, the lack of 
psychological services in the treatment settings, and 
the complex pathways that women with breast cancer 
care have to navigate to receive their treatment.
Therefore, the purpose of this study is to assess the 
QoL and the prevalence of PTSD symptoms among 
adult female patients with cancer attending Beit-Jala 
Governmental Hospital in the Bethlehem district in 
Palestine.
2. Materials and methods
This cross-sectional study included 253 female 
patients with cancer in the Oncology Department at 
the Beit-Jala Governmental Hospital in Bethlehem 
city.
Sample-size calculations, based on the expected 
prevalence of PTSD among patients with breast cancer 
of 9%, a 95% confidence interval (CI), and a 5% 
absolute precision on either side of the proportion, 
indicated that the minimum required sample size 
was 117 patients. Assuming a non-response rate of 
50%, 175 female patients would represent an adequate 
sample.
The questionnaire consisted of three sections. The 
first section included socio-demographic characteristics 
(marital status, place of residence, educational level, and 
economic status) and the patient’s medical history (can-
cer type, cancer treatment, and the onset of cancer 
diagnosis). To exclude previous psychological problems 
such as exposure to trauma or childhood maltreatment 
and neglect, several questions that assessed the psycho-
logical history of the participants were added. For 
example, the participants were asked whether they suf-
fered from any psychological problems before their 
cancer diagnosis, what those problems were, what type 
of psychological treatment(s) they had received, and 
whether they had considered harming themselves after 
they had been diagnosed with cancer. Their answers 
were negative for all of these questions as none of the 
participants reported having any psychological pro-
blems before their cancer diagnosis. Moreover, none 
of them reported thinking about harming themselves 
after being diagnosed with cancer.
The second section included the most recent ver-
sion of the European Organisation for Research and 
Treatment of Cancer (EORTC) Quality of Life 
Questionnaire Core 30 (QLQ-C30, version 3.0). This 
is composed of multi-item scales which measure the 
QoL of cancer patients using five functional scales 
(physical, role, cognitive, emotional, and social func-
tioning), three symptom scales (pain, fatigue, nausea 
and vomiting), and six single items (dyspnoea, insom-
nia, loss of appetite, constipation, diarrhoea, and 
financial impact). The four-point Likert-type response 
categories are ‘not’, ‘a little’, ‘quite a bit’, or ‘very 
much’. Items measuring global health and QoL 
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perception have seven-point response scales (EORTC, 
2001). The scoring algorithm recommended by the 
EORTC transforms the responses to values on a scale 
of 0–100%. For the functional scales and GQoL, a 
higher score corresponds to better functioning and 
QoL. For symptom scales, a higher score corresponds 
to more frequent and/or more intense symptoms 
(EORTC, 2001).
Finally, the third section was a post-traumatic 
disorder checklist, measuring PTSD symptoms. 
The PTSD Checklist specific version (PCL-S) is a 
17-item scale based on the Diagnostic and 
Statistical Manual of Mental Disorders, 4th 
Edition (DSM-IV) criteria, which is very similar 
to PCL-5 in DSM-5 (Weathers et al., 2013). It is a 
self-administered instrument that assesses symp-
toms using Likert-type responses (1: ‘not at all’, 2: 
‘a little bit’, 3: ‘moderately’, 4: ‘quite a bit’, and 5: 
‘extremely’) (Blanchard, Jones-alexander, Buckley, 
& Forneris, 1996). The PCL is scored by summing 
all items for a total of severity score (Weathers, 
Huska, & Keane, 1991). The score ranges from 17 
to 85, with a diagnostic cut-off score of 50 indicat-
ing the diagnosis of clinically significant PTSD 
(EORTC, 2001). A score of 1–18 indicates no 
PTSD symptoms, 19–34 indicates mild symptoms, 
35–52 indicates moderate symptoms, and 53–85 
indicates severe symptoms (Weathers et al., 1991). 
The content validity of our questionnaires was 
examined by a committee of four professionals in 
mental and public health. No changes were 
recommended.
The study was conducted in Beit-Jala 
Governmental Hospital, which is the main hospital 
in the governance and serves as a referral centre for 
cancer diagnosis and treatment in southern Palestine. 
Female patients with cancer, aged 18 years and older, 
who receive care in the oncology outpatient clinics and 
Day Care Unit at the Central Oncology Hospital in 
Palestine were recruited.
Written informed consent was obtained, and con-
fidentiality and privacy were assured for all partici-
pants. Al-Quds University Review Board granted 
ethical approval for the study.
2.1. Data analysis
SPSS version 20 was used for data analysis. 
Descriptive analyses (frequencies and means) of 
the sample’s characteristics were computed. The 
relationships between background variables (socio- 
demographic variables, cancer type, and treatment) 
and both QoL and PTSD were examined with one- 
way analysis of variance (ANOVA) and the t-test 
for continuous variables. Tukey’s post-hoc test was 
used after ANOVA significance had been calculated 
to determine how the specific groups’ means 
compared to one another. The chi-squared test 
was used to assess the relationship between PTSD 
groups and the background variables. Correlations 
were used to measure the association between 
symptoms, QoL domains, and PTSD scores. 
Predictors of PTSD severity were assessed using 
logistic regression. Cronbach’s alpha was 88.6 for 
the QoL scale and 89.9 for PTSD, which indicated 
good reliability.
3. Results
3.1. Socio-demographic and clinical 
characteristics
A total of 253 patients were recruited to participate 
in the study. Table 1 shows the socio-demographic 
and clinical characteristics of the participants. The 
mean age was 52.6 years, with a range of 20–81 
years. The majority were married (77.9%, n = 197). 
Most had breast cancer (85%, n = 215) and 15% 
(n = 38) had other types of cancer, including colon, 
stomach, bone, endometrial, liver, biliary, thyroid, 
ovarian, leukaemia, and lymphoma.
3.2. Means of EORTC QoL domains
The mean for GQoL was 57.4 (SD = 18.9) and the 
mean for physical functioning was 48.5 (SD = 26.30). 
Both were lower than average. On the other hand, the 
mean for role functioning was 64.3 (SD = 31.7), for 
emotional functioning was 77.8 (SD = 27), and for 
cognitive functioning was 77 (SD = 25.7). The mean 
for social functioning was 87.7 (SD = 24.6), which was 
higher than all the other domains. The mean of the 
financial impact of cancer on QoL was 25.2 
(SD = 31.5).
On the symptoms scale, insomnia, fatigue, and loss 
of appetite were the most troublesome to participants. 
Pain, constipation, and dyspnoea came in second, 
Table 1. Socio-demographic and clinical characteristics of the 
participants.
Variable Frequency Percentage (%)
Age (years) 18–40 49 19.4
41–50 62 24.5
51–60 66 26.1
> 61 76 30
Marital status Single 17 6.7
Married 197 77.9
Widow 39 15.4




Place of residence City 95 37.5
Village 148 58.5
Camp 10 4
Cancer type Breast 251 85
Others 38 15
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while nausea and vomiting were of the least concern 
(Table 2).
3.3. PTSD Checklist (PCL-S) results
PTSD symptoms are considered to be clinically sig-
nificant when the PCL-S score is 50 or above. The 
prevalence of PTSD among our participants using 
the cut-off of 50 was 3% (n = 8). In addition, the 
participants had PTSD symptoms based on the 
PTSD symptom score categories; 2% (n = 5) of parti-
cipants had severe PTSD symptoms, 23.3% (n = 59) 
had moderate, and 68.8% (n = 174) had mild symp-
toms. PTSD symptoms were absent in only 5.9% 
(n = 15) of the study participants (Table 3).
3.4. Factors associated with QoL and PTSD scale 
scores
Statistically, there were significant relationships 
(p < 0.05) between the QoL domains and age group, 
educational level, and cancer type and treatment. 
ANOVA showed that the only significant differences 
between the means of GQoL, cognitive functioning, 
role function, and physical functioning were attribu-
ted to age (p < 0.05), in favour of the younger age 
group, whereas social functioning was found to be in 
favour of the older age group (Table 4).
The results of the t-test demonstrated a significant 
difference between the means of physical functioning, 
role functioning, and social functioning (p < 0.05) attrib-
uted to cancer type. Patients with breast cancer had 
better physical functioning, role functioning, and social 
functioning than those with other types of cancer.
Significant relationships (p < 0.05) were found 
among PTSD severity, age group, and cancer type. In 
general, if PTSD symptoms were present in the 
younger age group, they were most likely to exist in 
the moderate range. Thus, patients with other types of 
cancer (colon, stomach, bone, endometrium, liver, 
biliary, thyroid, ovarian, leukaemia, and lymphoma) 
had more PTSD symptoms than those with breast 
cancer. On the other hand, there were no statistically 
significant relationships among PTSD, marital status, 
educational level, place of residence, cancer treatment, 
or length of cancer diagnosis (Table 5).
3.5. Relationships between QoL and PTSD
Significant negative relationships were found between 
PTSD and physical function (r = −0.32), role function 
(r = −0.38), social functioning (r = −0.48), emotional 
functioning (r = −0.57), and cognitive functioning 
domains (r = −0.23), and the GQoL (r = 0.46). This 
means that while GQoL and the functional domains 
were decreasing, PTSD symptoms were increasing at 
the same time. The strongest relationship was with 
emotional functioning; when emotional functioning 
decreased, PTSD symptoms increased (Table 6).
On the other hand, there were significant positive 
relationships between PTSD and pain (r = 0.43), fati-
gue (r = 0.48), nausea and vomiting (r = 0.28), dys-
pnoea (r = 0.20), insomnia (r = 0.52), loss of appetite 
(r = 0.40), and constipation (r = 0.31). As these symp-
toms increased, PTSD symptoms increased as well. 
The strongest relationship was with insomnia, while 
the weakest was with dyspnoea. There was a signifi-
cant positive relationship between PTSD and financial 
impact (r = 0.21); as cancer impacted a patient’s 
finances, her PTSD symptoms increased (Table 6).
3.6. Predictors of PTSD symptom severity
Multivariate logistic regression was performed to con-
trol confounders and assess predictors of PTSD symp-
tom severity. Consequently, variables were adjusted 
and all possible confounders were controlled. Age, 
physical and emotional functions, and insomnia were 
Table 2. Means and standard deviations for global quality of 
life (GQoL), functional, and symptoms domains in the quality 
of life questionnaire.
QoL domains Mean SD
Global quality of life (GQoL) 57.4 18.9
Functional domains†
Physical functioning (PF) 48.5 26.3
Role functioning (RF) 64.3 31.7
Emotional functioning (EF) 77.8 27
Cognitive functioning (CF) 77 25.7
Social functioning (SF) 87.7 24.6
Symptoms‡
Fatigue (FA) 36.7 26.3
Nausea and vomiting (NV) 15.1 22.5
Pain (PA) 27.2 26
Dyspnoea (DY) 24.1 31.3
Insomnia (SL) 37.4 39.5
Loss of appetite (AP) 35.4 36.4
Constipation (CO) 27 35.4
Diarrhoea (DI) 11.5 23
Financial difficulties (FI) 25.2 31.5
†Higher means indicate better GQoL and functioning. 
‡Higher means indicate higher symptom severity and worse financial 
difficulties.
Table 3. Prevalence of post-traumatic stress disorder (PTSD) 
and severity of PTSD symptoms based on the PTSD Checklist 
specific version (PCL-S).
PCL-S
Clinical PTSD symptoms using cut-off point of 50
Frequency Percentage (%)
No PTSD 248 97
PTSD 8 3
Total 253 100
Severity of PTSD symptoms
PTSD severity PCL-S score Frequency Percentage (%)
No PTSD (1–18) 15 5.9
Mild (19–34) 174 68.8
Moderate (35–52) 59 23.3
Severe (53–85) 5 2
Total 253 100
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the significant predictors of PTSD severity. 
Participants with severe PTSD symptoms were older 
and had better physical functioning, while those with 
higher emotional functioning had lower PTSD symp-
tom levels. Finally, participants who reported insom-
nia were most likely to have severe PTSD symptoms 
(Table 7) (Quinn et al., 2015).
4. Discussion
QoL in the current study (57.4%) is low in compar-
ison with the female international reference value 
determined by EORTC (59.3%). However, this differ-
ence is higher than in other national studies in the 
region, which showed a mean GQoL of 41.8% for 
Palestinian patients with cancer (Imam & Khleif, 
2013) and 45.3% for breast cancer patients in 
Kuwait (Alawadi & Ohaeri, 2009). On the other 
hand, patients with breast cancer in Turkey had a 
higher GQoL (62.8%) (Demirci et al., 2011) than in 
the current study.
Large cohort studies of women with breast can-
cer, such as the US Nurses’ Health study, which 
studied 122,969 patients, of whom 1082 were diag-
nosed with breast cancer, documented a decline in 
health-related QoL in multiple domains, including 
physical roles, pain, social functioning, and psy-
chosocial dimensions, after the breast cancer diag-
nosis (Kroenke et al., 2004). In our study, the 
physical domain had a negative impact on QoL 
and a mean of 48.4%, which was much lower than 
the female international reference value created by 
EORTC (74.4%). Ferrell, Dow, and Grant (1995) 
found that cancer survivors had several proble-
matic physical effects that influenced their ability 
to function and negatively influenced their overall 
QoL. The most common symptoms that affected 
physical well-being were pain and fatigue, while 
others included the psychological along with the 
physical domain as being troublesome to the QoL 
of patients with cancer (Pinar, Salepc, & Affiar, 
2003).
The high social and emotional functioning in our 
study may be attributed to the fact that social supports 
(family members and friends) are strong. Local cul-
tural values of the nuclear family and extended family 
Table 5. Chi-squared results of the relationships and differences in post-traumatic stress disorder (PTSD) severity due to socio- 
demographic and cancer medical history.
Variable/category No PTSD Mild PTSD Moderate PTSD Severe PTSD p
Age (years) 20 to < 40 % 12.2% 46.9% 38.8% 2.0% 0.02
Std. residual 1.8 −1.8 2.2 0
40 to < 50 Count % 3.2% 72.6% 21.0% 3.2%
Std. residual −0.9 0.4 −0.4 0.7
50 to < 60 Count % 7.6% 69.7% 21.2% 1.5%
Std. residual 0.5 0.1 −0.4 −0.3
≥ 60 Count % 2.6% 78.9% 17.1% 1.3%
Std. residual −1.2 1.1 −1.1 −0.4
Cancer type Other CA Count% 2.6% 57.9% 36.8% 2.6% 0.04
Std. residual −0.8 −0.8 1.7 0.3
Breast cancer Count % 6.5% 70.7% 20.9% 1.9%
Std. residual 0.4 0.3 −0.7 −0.1
Marital status Single % 5.9% 70.6% 23.5% 0.0% 1.00
Std. residual 0.0 0.1 0.0 −0.6
Married % 6.1% 68.0% 23.4% 2.5%
Std. residual 0.1 −0.1 0.0 0.6
Widow % 5.1% 71.8% 23.1% 0.0%
Std. residual −0.2 0.2 0.0 −0.09
Educational level None % 4.9% 76.7% 17.5% 1.0% 0.11
Std. residual −0.4 1.0 −1.2 −0.7
Primary % 5.5% 69.1% 20.0% 5.5%
Std. residual −0.1 0.0 −0.5 1.8
Secondary % 4.8% 58.7% 34.9% 1.6%
Std. residual −0.4 −1.0 1.9 −0.2
Higher % 12.5% 62.5% 25.0% 0.0%
Std. residual 1.5 −0.4 0.2 −0.8
Treatment Chemotherapy % 7.1% 67.9% 23.2% 1.8% 0.59
Std. residual 0.4 −0.1 0.0 −0.1
Chemotherapy and surgery % 5.9% 68.4% 24.1% 1.6%
Std. residual 0.0 −0.1 0.2 −0.4
Other treatment modalities % 0.0% 80.0% 10.0% 10.0%
Std. residual −0.8 0.4 −0.9 1.8
Length of diagnosis (months) < 6 % 8.6% 63.0% 25.9% 2.5% 0.54
Std. residual 1.0 −0.6 0.5 0.3
6 to < 12 % 4.3% 68.1% 26.6% 1.1%
Std. residual −0.7 −0.1 0.7 −0.6
12 to < 24 % 6.3% 75.0% 17.2% 1.6%
Std. residual 0.1 0.6 −1.0 −0.2
≥ 24 % 0.0% 78.6% 14.3% 7.1%
Std. residual −0.9 0.4 −0.7 1.4
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provide substantial support. Other research shows the 
value of emotional, informational, and logistical sup-
port, in addition to their impact on improved emo-
tional functioning (Adler, 2008). Cancer patients are 
often told that they should ‘think positively’ and ‘fight 
cancer’, which may result in their perceiving that by 
expressing fear or sadness they would be considered 
‘weak’. Furthermore, some patients fear that negative 
emotions may adversely affect their immune system. 
Processing these emotions may lead to a stronger 
emotional position, whereas suppressing them may 
increase the risk of depression and lead to sleep diffi-
culties (Leano, Korman, Goldberg, & Ellis, 2019).
Insomnia was the most commonly reported symp-
tom, followed by fatigue and loss of appetite. Studies 
show that rates of fatigue among women with cancer 
vary greatly, ranging from 4% in patients with breast 
cancer before the start of chemotherapy to 91% in 
breast cancer patients after surgery and chemotherapy 
(Carr et al., 2002). While insomnia was reported to be 
18.46% in patients with breast cancer, clinically signifi-
cant insomnia was highly associated with joint pain, hot 
flushes, age, and anxiety and depression since the breast 
cancer was first diagnosed (Desai et al., 2013).
Prevalence rates of PTSD varied widely depend-
ing on the method of assessment. Studies using 
self-reported PTSD symptoms measured yielded 
prevalence estimates of clinically significant symp-
tom levels from 7.3% (95% CI 4.5–11.7; 10 studies) 
to 13.8% (9.5–19.6; 11 studies) depending on the 
screening and scoring method used (Abbey, 
Thompson, Hickish, & Heathcote, 2015). Other 
studies showed a higher percentage of PTSD symp-
toms than in healthy people. For example, a study 
conducted in Germany to measure psychosocial 
comorbidity and QoL, which assessed PTSD with 
the PTSD Checklist civilian version (PCL-C), 
revealed PTSD rates of 12% in long-term breast 
cancer survivors (Aqeel et al., 2019). Another 
study that looked at PTSD prevalence using DSM- 
IV criteria, which is the same tool that we used, 
showed that the prevalence changed, being lower in 
early diagnosis and increasing at 4 years and 
upwards (Chan et al., 2018). In our study, PTSD, 
as a clinically significant diagnosis using the cut-off 
score of 50, as recommended (Aqeel et al., 2019), 
shows a lower prevalence at 3%, and more severe 
symptoms among participants with cancers other 
than breast cancer. However, most of our partici-
pants had PTSD symptoms and only 5.9% reported 
no symptoms. Our study indicates that a better 
QoL is associated with lower PTSD symptoms. It 
also shows that the main predictors of PTSD sever-
ity are age, physical functioning, emotional func-
tioning, and sleep pattern. The same association 
was expressed in a study conducted in the USA, 
where health-related QoL was significantly asso-
ciated with PCL-C scores (Hahn et al., 2015). 
‘Cancer’, which is usually associated with 
Table 6. Adjusted relationships between post-traumatic stress disorder (PTSD) symptoms and quality of life†.
Dependent variable Multiple correlation r-square F-value ANOVA p-value B-value (regression) p-value
Physical function 0.53 0.28 23.93 0.00 −15.28 0.001*
Role function 0.46 0.21 16.29 0.00 −20.82 0.001*
Social functioning 0.52 0.27 22.68 0.00 −19.15 0.001*
Emotional functioning 0.58 0.34 31.76 0.00 −26.49 0.001*
Cognitive functioning 0.49 0.24 19.70 0.00 −11.83 0.001*
Pain 0.50 0.25 20.55 0.00 18.82 0.001*
Fatigue 0.56 0.31 28.08 0.00 21.38 0.001*
Nausea and vomiting 0.35 0.12 8.72 0.00 9.85 0.001*
Dyspnoea 0.28 0.08 5.17 0.00 11.73 0.001*
Insomnia 0.55 0.30 26.81 0.00 34.50 0.001*
Loss of appetite 0.46 0.21 16.59 0.00 25.98 0.001*
Constipation 0.43 0.18 13.95 0.00 19.16 0.001*
Diarrhoea 0.19 0.04 2.25 0.07 −3.19 0.16
Financial impact 0.28 0.08 5.10 0.00 11.92 0.001*
Global quality of life 0.50 0.25 20.56 0.00 −15.16 0.001*
†Independent variable: PTSD symptoms; adjusted for age, cancer type, and treatment. 
*Significant at the 0.05 level.
Table 7. Logistic regression: predictors of post-traumatic stress 
disorder symptom severity.
β SE Adjusted OR p
Age 0.25 0.13 1.3 0.05*
Cancer type 0.15 1.8 1.01 0.9
Physical function 0.23 0.11 1.3 0.03*
Role function −0.03 0.04 1 0.4
Social functioning −0.03 0.02 0.96 0.2
Emotional functioning −0.13 0.06 0.8 0.03*
Cognitive functioning 0.06 0.04 1.1 0.1
Pain 0.07 0.07 1.1 0.3
Fatigue 0.02 0.05 1 0.6
Nausea and vomiting −0.07 0.05 0.9 0.1
Dyspnoea 0.03 0.02 1 0.2
Insomnia 0.12 0.62 1.2 0.05*
Loss of appetite 0.04 0.03 1.04 0.3
Constipation 0.02 0.027 1.02 0.2
Diarrhoea 0.02 0.5 1 0.8
Financial impact −0.003 0.03 0.97 0.4
Global quality of life −0.0.3 0.36 0.97 0.4
OR, odds ratio. 
*Significant at the 0.05 level.
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chemotherapy, hair loss, nausea, and other physical 
symptoms, has a significant emotional impact on 
patients. A study in Eastern Europe found that 40% 
of patients with cancer experience significant emo-
tional distress during treatment, which is signifi-
cantly associated with PTSD symptoms (Pranjic, 
Bajraktarevic, & Ramic, 2016).
Therefore, interventions for moderate PTSD symp-
toms should concentrate on improving psychological 
well-being. Successful interventions have aimed to 
improve psychosocial involvement, psychological 
understanding, and religious involvement (Desai et al., 
2013), and have been implemented early (Levine, 
Eckhardt, & Targ, 2005). In addition, results show sig-
nificant positive relationships between pain, fatigue, 
nausea and vomiting, dyspnoea, insomnia, loss of appe-
tite, and constipation and PTSD. Thus, the increase in 
the severity of cancer symptoms was associated with an 
increase in the PTSD symptoms score. Jones (2001) 
highlighted that as the physical symptoms of the disease 
decrease, the symptoms of psychological distress will 
resolve over time in the majority of women.
Our findings indicate that PTSD symptoms inter-
fere with patient functioning. Therefore, it is the 
responsibility of health practitioners to educate the 
patients, their family members, and caregivers regard-
ing normal and expected symptoms related to diag-
nosis and treatment, including the range of emotional 
responses. The American Cancer Society recommends 
that healthcare workers should provide patients with 
safe and competent care, including a comprehensive 
psychosocial assessment for PTSD, individualized 
interventions, and referral when appropriate 
(American Cancer Society, 2009).
5. Conclusion and limitations
It is important that female patients with cancer 
undergo a careful assessment for PTSD, as well as 
the various components that support QoL, such as 
social and emotional supports as well as adequate 
treatment of pain. Timely identification and treatment 
may improve QoL.
The study utilizes a quick assessment of PTSD 
prevalence, which is based on the DSM-IV and 
does not include all of the DSM-5 diagnostic cri-
teria (Haddou Rahou et al., 2016; Weathers et al., 
2013). It is impossible to repeat the data collection 
or to analyse the PTSD criteria in the checklist for 
the DSM-5 criteria. The DSM-5 criteria pay more 
attention to the behavioural symptoms that accom-
pany PTSD and propose four distinct diagnostic 
clusters instead of three (APA, 2013). This may 
have captured more symptomology in our partici-
pants, thus increasing the scores. The nature of the 
cross-sectional design also makes it impossible to 
compare how factors change over time. Despite 
these limitations, we present important findings 
for an area of the world where there has been little 
research on women and breast cancer related to 
QoL and PTSD. Our findings shows that the strong 
social support in the local culture appears to 
improve the QoL for cancer patients. Future 
research may look at PTSD and QoL differences 
at different intervals in the diagnosis, or how inter-
ventions could improve patient function.
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